Abstract
Toxoplasma gondii is a worldwide spread protozoan and is able to infect almost all warm-blood animals. No effective drugs are available clinically on toxoplasmosis. Chinese traditional herbal medicines have provided remedies for many health problems. There exists a possibility that Chinese herbs may provide protection against T. gondii. This work aims to assess the protective efficacy of combined Chinese herbs against T. gondii. We screened five herbal medicines that have different pharmacological effects and combined them into a prescription according to the traditional Chinese medicine compatibility principle. The drug potential and protective efficacy were evaluated through a mouse model by determining the survival time, the parasite load in blood and tissues, the change of cell proportions in blood and histological detection. The results showed that the survival time of mice in the 500 mg Chinese herbs group and sulfadiazine group was significantly longer than that of the PBS control group. Also the parasite load in blood and tissues of 500 mg Chinese herbs and sulfadiazine groups was significantly lower than that of PBS group at 7 days post infection (dpi), which was in accordance with the result of histological detection. Monocyte and neutrophil of infected mice were remarkably increased while lymphocyte was dramatically decreased compared to that of blank group at 7 dpi. The results demonstrated that the 500 mg dosage of our Chinese herbs could slow down the replication of T. gondii and prolong the survival time of mice and could be considered as possible candidate drug against toxoplasmosis.
摘要
目的
评估复方中草药对小鼠抗弓形虫的保护力,以期 找到新型防治弓形虫病的药物。
创新点
首次在小鼠模型中研究威灵仙、芜荑、白术、刘 寄奴和甘草组成的复方中草药的抗弓形虫功效, 并发现500 mg 的药物能提供较好的保护力。
方法
将ICR 雌性小鼠随机分为7 组:空白组不攻虫不 给药;PBS 组攻虫;药物对照组攻虫并口服磺胺 嘧啶10 mg/d;实验组攻虫并分别灌胃300、400、 500 和600 mg/d 中药煎剂;攻虫组每只小鼠腹腔 注射弓形虫RH 株1000 个。每日观察各组小鼠死 亡情况,在感染后3 和7 d 采集抗凝血检测血常 规,并采集血液、肝、脾和肺组织,提取基因组 DNA,通过绝对荧光定量PCR 检测各组织样品 中的虫荷量,采集感染后7 d 的肝、肺和脾组织, 制作组织切片,通过H & E 染色观察组织病变情 况。
结论
试验结果表明,500 mg 中药组及磺胺嘧啶药物对 照组的小鼠显著地延长了存活时间(图1),且这两组小鼠组织及血液中的虫荷数显著低于其 他组(图2),这与小鼠的肝、肺和脾组织病理 染色结果一致(图4)。另外,与300、400 和 600 mg 中药处理组相比,500 mg 处理组小鼠的 单核细胞和淋巴细胞比例均较低(图3),这在 一定程度上阻碍了弓形虫在血细胞中的传播。综 上所述,500 mg 中草药处理组能降低弓形虫的胞 内增殖速率,延长小鼠的存活时间,证明该浓度 的复方中药具有一定的抗弓形虫效果。
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bell, A., Ranford-Cartwright, L., 2002. Real-time quantitative PCR in parasitology. Trends Parasitol., 18(8):338–342. http://dx.doi.org/10.1016/S1471-4922(02)02331-0
Cinatl, J., Morgenstern, B., Bauer, G., et al., 2003. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet, 361(9374):2045–2046. http://dx.doi.org/10.1016/S0140-6736(03)13615-X
Dadimoghaddam, Y., Daryani, A., Sharif, M., et al., 2014. Tissue tropism and parasite burden of Toxoplasma gondii RH strain in experimentally infected mice. Asian Pac. J. Trop. Med., 7(7):521–524. http://dx.doi.org/10.1016/S1995-7645(14)60087-0
Fischer, A.H., Jacobson, K.A., Rose, J., et al., 2008. Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harb. Protoc., 2008(5):pdb.prot4986. http://dx.doi.org/10.1101/pdb.prot4986
Furtado, J.M., Winthrop, K.L., Butler, N.J., et al., 2013. Ocular toxoplasmosis I: parasitology, epidemiology and public health. Clin. Exp. Ophthalmol., 41(1):82–94. http://dx.doi.org/10.1111/j.1442-9071.2012.02821.x
Innes, E.A., 2010a. A brief history and overview of Toxoplasma gondii. Zoonoses Public Hlth., 57(1):1–7. http://dx.doi.org/10.1111/j.1863-2378.2009.01276.x
Innes, E.A., 2010b. Vaccination against Toxoplasma gondii: an increasing priority for collaborative research? Expert Rev. Vacc., 9(10):1117–1119. http://dx.doi.org/10.1586/erv.10.113
Jongert, E., Roberts, C.W., Gargano, N., et al., 2009. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem. Inst. Oswaldo Cruz., 104(2):252–266. http://dx.doi.org/10.1590/S0074-02762009000200019
Kur, J., Holec-Gasior, L., Hiszczynska-Sawicka, E., 2009. Current status of toxoplasmosis vaccine development. Expert Rev. Vaccines, 8(6):791–808. http://dx.doi.org/10.1586/erv.09.27
Lachenmaier, S.M., Deli, M.A., Meissner, M., et al., 2011. Intracellular transport of Toxoplasma gondii through the blood-brain barrier. J. Neuroimmunol., 232(1):119–130. http://dx.doi.org/10.1016/j.jneuroim.2010.10.029
Li, C., Ying, Q., Su, X., et al., 2012. Development and application of reverse transcription loop-mediated isothermal amplification for detecting live Shewanella putrefaciens in preserved fish sample. J. Food Sci., 77(4): M226–M230. http://dx.doi.org/10.1111/j.1750-3841.2012.02636.x
Machado, A.S., Carneiro, A.C., Bela, S.R., et al., 2014. Biomarker analysis revealed distinct profiles of innate and adaptive immunity in infants with ocular lesions of congenital toxoplasmosis. Mediat. Inflamm., 2014:910621. http://dx.doi.org/10.1155/2014/910621
Mack, D.G., McLeod, R., 1984. New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A. Antimicrob. Agents Chemother., 26(1):26–30. http://dx.doi.org/10.1128/AAC.26.1.26
Mordue, D.G., Sibley, L.D., 2003. A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis. J. Leukoc. Biol., 74(6):1015–1025. http://dx.doi.org/10.1189/jlb.0403164
Na-Bangchang, K., Karbwang, J., 2014. Traditional herbal medicine for the control of tropical diseases. Trop. Med. Health, 42(2 Suppl.):S3–S13. http://dx.doi.org/10.2149/tmh.2014-S01
National Pharmacopoeia Committee, 2010. Pharmacopoeia of People Republic of China. Chemical Industry Press, Beijing, China (in Chinese).
Noh, E.M., Lee, Y.R., Hur, H., et al., 2011. Radix clematidis extract inhibits TPA-induced MMP-9 expression by suppressing NF-κB activation in MCF-7 human breast cancer cells. Mol. Med. Rep., 4:879–883. http://dx.doi.org/10.3892/mmr.2011.532
Petersen, E., Schmidt, D.R., 2003. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? Expert Rev. Anti-infect. Ther., 1(1):175–182. http://dx.doi.org/10.1586/14787210.1.1.175
Qu, D., Han, J., Du, A., 2013. Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re. Exp. Parasitol., 135(2):234–239. http://dx.doi.org/10.1016/j.exppara.2013.07.013
Robben, P.M., LaRegina, M., Kuziel, W.A., et al., 2005. Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis. J. Exp. Med., 201(11):1761–1769. http://dx.doi.org/10.1084/jem.20050054
Romand, S., Chosson, M., Franck, J., et al., 2004. Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii. Am. J. Obstet. Gynecol., 190(3): 797–802. http://dx.doi.org/10.1016/j.ajog.2003.09.039
Shen, G., Wang, X., Sun, H., et al., 2016. Seroprevalence of Toxoplasma gondii infection among HIV/AIDS patients in eastern China. Korean J. Parasitol., 54(1):93–96. http://dx.doi.org/10.3347/kjp.2016.54.1.93
Tan, X., Wang, Y.L., Yang, X.L., et al., 2014. Ethyl acetate extract of Artemisia anomala S. Moore displays potent anti-inflammatory effect. Evid. Based Complement. Alternat. Med., 2014:681352. http://dx.doi.org/10.1155/2014/681352
Yu, H., Huang, B., Zhuo, X., et al., 2013. Evaluation of a real-time PCR assay based on the single-copy SAG1 gene for the detection of Toxoplasma gondii. Vet. Parasitol., 197(3):670–673. http://dx.doi.org/10.1016/j.vetpar.2013.06.013
Zheng, B., Lu, S., Tong, Q., et al., 2013. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice. Vaccine, 31(41):4578–4584. http://dx.doi.org/10.1016/j.vaccine.2013.07.058
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Science and Technology Department of Zhejiang Province (No. 2012C12009-2), China
ORCID: Ai-fang DU, http://orcid.org/0000-0002-3796-6621
Rights and permissions
About this article
Cite this article
Zhuo, Xh., Sun, Hc., Huang, B. et al. Evaluation of potential anti-toxoplasmosis efficiency of combined traditional herbs in a mouse model. J. Zhejiang Univ. Sci. B 18, 453–461 (2017). https://doi.org/10.1631/jzus.B1600316
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B1600316